Manufacturing-ready Horizon CHO cells
- Accelerate cell line development
- Meet demands for cost-effective biomanufacturing
- Licensed to over 50 companies worldwide
Glenmark adopted Horizon CHO cell line (GS knockout CHO K1) into their biomanufacturing process to enhance ability to generate high quality cell lines that consistently demonstrated impressive performance. Read more on how we empower pharmaceutical companies by driving efficiencies in biotherapeutic manufacturing.
Use CRISPR screening to optimize your CHO cell line